Status:
RECRUITING
The Effect of Standard Cognitive-behavioral Therapy+Transcranial Alternating Current on Refractory Insomnia Disorder
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Insomnia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to investigate the efficacy of CBTI + transcranial alternating current (TAC) technology in the treatment of refractory insomnia and the mechanism of 'cognitive-behavi...
Detailed Description
Difficult to treat insomnia is a sleep disorder that significantly reduces the quality of sleep for patients, seriously affecting their daily work and study. At present, the main treatment method for ...
Eligibility Criteria
Inclusion
- Meets the diagnostic criteria for insomnia in DSM-5;
- Pittsburgh Sleep Quality Index (PSQI) total score\>5 points;
- Age ≥ 18 years old, with a junior high school education or above;
- Voluntarily participate in this study and sign an informed consent form.
Exclusion
- Individuals with severe physical or mental illnesses are at risk of suicide;
- Clinically diagnosed or suspected sleep breathing disorders, restless leg syndrome, and sleep wake rhythm disorders, as well as workers on rotating shifts;
- Pregnant and lactating women;
- Currently undergoing any psychological therapy.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06969040
Start Date
November 1 2024
End Date
November 1 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, China, 100053